MedTrace Logo

Early Detection of Lung Cancer

NCT03181256 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2026-05-05

No results posted yet for this study

Summary

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.

Conditions

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of sputum

PROCEDURE

Biospecimen collection

Undergo collection of nasal epithelium

PROCEDURE

Biospecimen collection

Undergo collection of buccal epithelium

PROCEDURE

Biospecimen collection

Undergo collection of blood

PROCEDURE

Biospecimen collection

Undergo collection of urine

PROCEDURE

Pulmonary Function Test

Undergo pulmonary function test

PROCEDURE

Computed Tomography (CT)

Undergo chest CT

OTHER

Laboratory Biomarker

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Eric Grogan, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2023-11-30
Completion
2026-11-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03181256 on ClinicalTrials.gov